Columnist Ben Hofmeister has just completed his third overnight sleep study in three years as part of an effort to control sleep apnea.
Inspire Medical Systems, Inc. is a Sell due to competitive pressures, reimbursement uncertainties & margin compression. Read ...
Istanbul: CPAP therapy does not affect Eustachian tube function, but understanding its side effects can improve patient ...
Fourth quarter revenue growth of 12% and full year revenue growth of 14%Fourth quarter net income per diluted share of $4.66; adjusted net income ...
A rival re-emerges, investors brace for impact and the Ozempic scare dissolves. ResMed’s growth story just got more interesting.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results